Clinical trial
Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
NCT00353665 · University of Lisbon, Other · Completed
Key facts
| NCT number | NCT00353665 |
|---|---|
| Title | Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS) |
| Official title | Phase 2-3 - Memantine for Disability in Amyotrophic Lateral Sclerosis |
| Lead sponsor | University of Lisbon, Other |
| Collaborators | H. Lundbeck A/S Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | Memantine (Ebixa), riluzole, Placebo |
| Enrollment | 63 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Jul 19, 2006 |
| Last update posted | Apr 1, 2009 |
| Countries | Portugal |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: